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INTRODUCTION 
 
Dilated cardiomyopathy (DCM) is a non-ischemic 
heart muscle disease with structural and functional 
myocardial abnormalities characterized by dilation of 
the ventricular chamber and impaired contraction [1]. 
Myocardial damage triggers inflammation followed 
by the recruitment of immune cells to the injured site 
and the release of cytokines [2, 3]. 
 
Furthermore, aging is considered to be a risk factor for 
cardiovascular diseases and to have a negative impact 
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Dilated cardiomyopathy (DCM) belongs to the myocardial diseases associated with a severe impairment of cardiac 
function, but the question of how sex and age affect this pathology has not been fully explored. Impaired energy 
homeostasis, mitochondrial dysfunction, and systemic inflammation are well-described phenomena associated 
with aging. In this study, we investigated if DCM affects these phenomena in a sex- and age-related manner.  
We analyzed the expression of mitochondrial and antioxidant proteins and the inflammatory state in DCM 
heart tissue from younger and older women and men. 
A significant downregulation of Sirt1 expression was detected in older DCM patients. Sex-related differences were 
observed in the phosphorylation of AMPK that only appeared in older males with DCM, possibly due to an 
alternative Sirt1 regulation mechanism. Furthermore, reduced expression of several mitochondrial proteins 
(TOM40, TIM23, Sirt3, and SOD2) and genes (cox1, nd4) was only detected in old DCM patients, suggesting that 
age has a greater effect than DCM on these alterations. Finally, an increased expression of inflammatory markers 
in older, failing hearts, with a stronger pro-inflammatory response in men, was observed. Together, these findings 
indicate that age- and sex-related increased inflammation and disturbance of mitochondrial homeostasis occurs in 
male individuals with DCM. 
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on ventricular function [4–7]. On the molecular level, 
aging is accompanied by a disturbance in energy 
homeostasis, mitochondrial dysfunction, and increased 
inflammation [4]. Importantly, sex differences in the 
mitochondrial function in several pathologies, including 
cardiovascular diseases, have been demonstrated [8]. 
Mitochondrial biogenesis and respiration are regulated 
by PGC-1α, a transcriptional coactivator, and its 
downregulation has been shown to lead to hypertrophy 
and heart failure [9–11]. Furthermore, the reduced 
activity of PGC-1α itself, as well as its modulators, 
especially AMP-activated kinase (AMPK) among 
others, has been associated with aging [12]. A decline in 
AMPK activity, a crucial regulator of energy metabolic 
homeostasis, has been shown in older subjects, and 
increasing this AMPK activity may extend lifespans 
[13]. Sirtuins (Sirt), a conserved family of global 
metabolic regulators with NAD
+
-dependent deacetylase 
activity [14], and Sirt1 (an evolutionarily conserved 
AMPK partner) in particular [15, 16], have been widely 
reported to protect against age-associated diseases and 
therefore, to increase health span and life span [17–21]. 
Consistent reduction of NAD
+
 levels in older mice is 
accompanied by a decrease in Sirt1 activity, while its 
genetic or pharmacological restoration promotes 
longevity [18, 22, 23].  
 
Among other factors, AMPK and Sirt1 play essential 
roles in mitochondrial biology. Particularly, AMPK and 
Sirt1 promote PGC-1α activity and, thus, mitochondrial 
biogenesis. Furthermore, AMPK controls mitochondrial 
clearance, i.e., mitophagy [24] and a decline in the 
AMPK activity leads to impaired mitophagy, 
accumulation of dysfunctional mitochondria, and ROS 
formation, which may trigger inflammation- and aging-
related diseases [4, 25, 26]. Additionally, the release of 
mtDNA from damaged mitochondria into the cytosol 
may lead to an inflammatory response, via Toll-like 
receptors and STING-dependent inflammasome 
activation [25]. Similarly, emerging data have suggested 
that Sirt1 may play an anti-inflammatory role [27–29]. 
 
In addition to Sirt1, Sirt3 is another sirtuin playing an 
essential role in mitochondrial biology. Sirt3 is the main 
mitochondrial-localized deacetylase that maintains the 
activity of numerous mitochondrial enzymes, e.g. 
SOD2, and thus, supports metabolic and redox balance 
in mitochondria [30]. Both we and others have shown a 
decline in Sirt3 expression in older human myocardium 
[31, 32]. It is important to note that an anti-
inflammatory role of mitochondria-localized Sirt3 has 
been reported [33, 34].  
 
Sex is another potential risk factor associated with 
cardiovascular diseases. Men have an increased 
incidence and severity of atherosclerosis, myocardial 
infarction, heart failure, and DCM [35–37], whereas 
women with DCM have better chances of survival than 
men [38]. Heart failure is associated with 
cardiomyocyte hypertrophy, apoptosis, inflammation, 
and interstitial fibrosis, which all occur in a sex-specific 
manner [39]. Estrogen (E2) seems to play a protective 
role, as a decline in its levels is associated with 
deleterious left ventricle remodeling and cardiac 
dysfunction [40]. 
 
Altogether, sex and age have significant impacts on 
cardiomyopathy, however, there is still a large gap in 
the research about signaling in heart diseases dependent 
on age or sex. Here, we investigated age- and sex-
related alterations in the expression of metabolic 
regulators, i.e., AMPK and Sirt1, mitochondrial bio-
genesis, and inflammation parameters in patients with 
DCM. The analyses revealed a decreased Sirt1 and Sirt3 
expression in older DCM patients in both sexes, 
whereas the activity of AMPK was increased only in 
men. Sex differences were also found in mitochondrial 
antioxidant capacity, e.g., SOD2. DCM in the hearts of 
older patients was associated with a reduced expression 
of mitochondrial proteins and increased inflammation, 




DCM-related Sirt1 and AMPK alterations in older 
patients 
 
Sirt1 and AMPK are key regulators of metabolic 
pathways. Previously, we observed a decreased 
expression of Sirt1 and AMPK in older individuals [32]; 
however, age- and sex-related differences in patients 
with DCM remained unexplored. Therefore, in the 
present study, the expression of Sirt1, AMPK, and 
pAMPK in control (non-diseased) and diseased human 
cardiac tissue from young and old male and females 
was analyzed.  
 
In older individuals, Sirt1 expression was significantly 
decreased in the DCM group when compared to the 
control (Figure 1A).  Both Sirt1 and AMPK share many 
common target molecules and interact with each other 
[15]. To test whether the Sirt1 downregulation is 
associated with the alteration of AMPK activity 
(indirectly highlighted by the phosphorylation rate), the 
pAMPK/AMPK ratio was analyzed. A significant 
increase in AMPK phosphorylation in older men with 
DCM, but not in women, in the presence of unchanged 
total AMPK content, was observed (Figure 1B, 1C). 
Surprisingly, the pAMPK/AMPK ratio was markedly 
reduced in younger individuals (Supplementary Figure 
1C). The linear regression analysis revealed a 
significant dependence of the DCM-related alteration in 
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the AMPK phosphorylation on age, with the threshold 
appearing at 40 years (Figure 1D). Therefore, DCM 
seems to have an opposite effect on AMPK 
phosphorylation in younger (downregulation) and older 
(upregulation) patients (Figure 1D).  
 
No significant changes in Sirt1 or in AMPK expression 
in younger individuals with DCM were found 
(Supplementary Figure 1A, 1B).  
 
DCM-related expression of mitochondrial and anti-
oxidative enzymes in older patients 
 
Disturbance of mitochondrial homeostasis, e.g., 
biogenesis, is a hallmark and a trigger of heart failure 
[41]. Therefore, markers of mitochondrial biogenesis 
were analyzed in cardiac tissue.  
 
PGC-1α is a key transcription co-activator involved in 
mitochondrial biogenesis and a direct target of Sirt1 
[42]. It has been shown that downregulation of Sirt1 
may impair PGC-1α activity [42], and, in turn, 
mitochondrial biogenesis [43].  
 
In the present study, the protein level of PGC-1α was 
affected neither in an age- nor in a sex-specific manner 
(Figure 2A and Supplementary Figure 2A). 
Nevertheless, the expression of several mitochondrial 
proteins (TOM40, TIM23, and Sirt3), as well as mRNA 
(cox1, mt-nd4) was markedly reduced in older but not in 
younger DCM patients (Figures 2, 3, Supplementary 
Figure 2 and Supplementary Figure 3, respectively). Of 
note is the significant reduction of the expression of a 
key anti-oxidative mitochondrial enzyme SOD2 solely 
in older male DCM patients (Figure 2E). In contrast, the 
expression of cytosolic anti-oxidative enzyme catalase 
was significantly upregulated in older DCM individuals 
of both sexes (Figure 2F). Taken together, our data 
suggest a disturbance in mitochondrial biogenesis and 




Figure 1. Effects of DCM on Sirt1 expression and AMPK phosphorylation in older patients. Expression analysis of Sirt1 mRNA (A), 
total AMPK (B) and phosphorylated AMPK (Thr172) (C) performed with human cardiac tissue lysates from old control (non-diseased) and 
DCM men (♂) and women (♀). Data are means ± SEM (n= 5). Representative imaging of western blot analysis; the lanes were run in two gels. 
All data were normalized to the corresponding control and expressed in relative units (r.u.). (D) Linear regression analysis between 
pAMPK/AMPK ratio (dependent variable) and age (explanatory variable) was performed with function lm() in R. pAMPK/AMPK values were 
obtained from old and young male and female hearts diagnosed with DCM.  
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DCM-related pro-inflammatory state alterations in 
older patients 
 
The cardiac pro-inflammatory state is expanded during 
aging processes [44]. Downregulation of Sirt1 and 
AMPK, along with mitochondrial dysfunction, may 
significantly contribute to the initiation and perpetuation 
of inflammation in the heart [45, 46]. Thus, we 
examined the data for alterations in the Sirt1 and 
AMPK signaling and mitochondrial homeostasis that 
were accompanied by a pro-inflammatory response in 
older DCM patients.  
 
The number of cardiac CD68 immune-reactive cells was 
markedly increased in older hearts with DCM when 
compared to the older control hearts (Figure 4A and 
Supplementary Figure 4). In accordance with this finding, 
the NF-κB expression was also significantly elevated in 
older male DCM hearts (Figure 4B). It has been suggested 
that FOXO1 is involved in the polarization of 
macrophages [47]. FOXO1 expression was significantly 
increased in older DCM patients (Figure 4C), further 
suggesting a DCM-related pro-inflammatory state.  
In contrast to these findings, the mRNA of pro-
inflammatory cytokines, e. g.  TNF-α was not changed in 
older DCM hearts (data not shown), and the IL-1β was 
significantly reduced in older DCM hearts in comparison 
to control hearts (Figure 4D). In contrast, IL-12 mRNA 
expression was significantly elevated in older male hearts. 
(Figure 4E). In addition, the mRNA of the anti-
inflammatory cytokine IL-10 was reduced in older male 
and female hearts (Figure 4F). Further analysis of the 
IL12/IL10 ratio revealed a significantly higher ratio in 
older male and female DCM hearts (ratio= 4.2 and 2.3) 
compared to control male or female hearts (1.0). (Figure 
4G) Altogether, the pro-inflammatory response in DCM is 




In the current study, we investigated age- and sex-
related alterations in metabolic, mitochondrial, and 
inflammatory markers in DCM patients. The main 
findings are as follows: 1) In older patients, DCM is 
associated with significant Sirt1 downregulation in both 




Figure 2. DCM-related alterations in expression of mitochondrial proteins and anti-oxidative enzymes in older patients. 
Western blot analysis of PGC1-α (A), TOM40 (B), TIM23 (C), Sirt3 (D), SOD2 (E) and catalase (F) expression performed with human cardiac 
tissue lysates from old control (non-diseased) or DCM men (♂) and women (♀). Representative imaging of western blot analysis; the lanes 
were run in two gels. All data were normalized to the corresponding control and expressed in relative units (r.u.).  Data are means ± SEM 
(n= 5).  
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Figure 3. DCM-related alterations in expression of mitochondrial genes in older patients. Real-time PCR analysis for the 
mitochondrial-encoded genes cox1 (A, B) and mt-nda (C, D) as well as the nuclear-encoded genes ndusf1 (E, F), performed with human 




Figure 4. DCM effects on the pro-inflammatory state. Immunohistological analysis of CD-68 immuno-reactive cells (A). Western blot 
analysis of NF-κB (B), FOXO1 (C) as well as the real-time PCR analysis of IL-1β (D), IL-12 (E), and IL-10 (F) mRNA expression performed with 
human cardiac tissue lysates from old control (non-diseased) or DCM men (♂) and women (♀). (G) Ratio of IL-12/IL-10. Representative 
imaging of western blot analysis. All data were normalized to the corresponding control and expressed in relative units (r.u.). Data are shown 
as the mean ± SEM (n= 5).  
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appeared in males; 2) expression of several 
mitochondrial proteins (TOM40, TIM23, and Sirt3), 
including a main mitochondrial antioxidant SOD2, and 
mRNA (cox1, nd4) is reduced in older but not in 
younger DCM patients; 3) expression of the 
inflammatory markers in older hearts with DCM is 
increased, with a stronger pro-inflammatory response in 
older males with DCM. Taken together, these findings 
indicate a disturbance of metabolic sensing, impairment 
of mitochondrial biogenesis, and increased inflam-
mation in older individuals with DCM in both sex-
dependent and -independent manners. 
 
The crucial role of Sirt1 in inflammation, DNA repair, 
apoptosis, and aging has already been investigated  
[48, 49]. Its reduced expression and activity have been 
associated with various pathologies, e.g., diabetes, 
Alzheimer's disease and coronary artery disease  
[50–52]. Sirt1 activation by resveratrol tends to 
decelerate aging processes and the onset of chronic 
diseases [53–55]. In the present study, the Sirt1 
expression was significantly diminished in DCM hearts 
in older individuals in a sex-independent manner, while 
no alterations were observed in younger DCM patients. 
In accordance with our data, consistent reduction of 
Sirt1 expression was reported in older mice [56] as well 
as in control hearts of older women. Likewise, Sirt1-
deficient mice showed a progressive DCM strongly 
associated with mitochondrial dysfunction [57]. 
Furthermore, reduced Sirt1 expression was reported in 
monocytes of older patients with cardiovascular 
diseases [52], suggesting that aging directly aggravates 
cardiac dysfunction via disruption of Sirt1 signaling, 
promoting mitochondrial dysfunction, apoptosis, and 
inflammation as a result. 
 
AMPK is a key Sirt1 partner in regulating metabolic 
activity and inflammation that is activated under 
metabolic stress [58]. AMPK and SIRT1 may regulate 
each other and share many common targets [15]. An 
increasing number of reports emphasize the supporting 
role of AMPK activity in cardiac metabolic homeostasis 
[59]. From the other side, persistent AMPK 
overactivation might be deleterious in some cases, with 
a chronic AMPK activation appearing to aggravate the 
pathological damage that strokes and myocardial 
ischemia cause [13, 60, 61], by, e.g., decreasing fatty 
acid oxidation [62]. Furthermore, sustained AMPK 
activation leads to excessive mitochondrial frag-
mentation and mitophagy, leading to the depletion of 
functional mitochondria [63]. Here, DCM in older 
patients was associated with increased phosphorylation 
of AMPK compared to the control group, whereas in 
young DCM patients AMPK phosphorylation was 
markedly reduced. Though diminished AMPK activity 
in hearts with DCM has been previously observed [61], 
no age dependence has been demonstrated. In fact, both 
we and others [13, 32] observed a marked reduction of 
the cardiac AMPK phosphorylation in older, control 
individuals. It is tempting to speculate that,  
with the reduced AMPK phosphorylation in older 
hearts, additional DCM-related metabolic impairment 
may trigger the compensatory activation of the  
AMPK phosphorylation. Fitting in with this view, 
decreased ATP levels are commonly observed in DCM 
patients [64]. 
 
The disturbance of metabolic homeostasis in older 
DCM hearts is further highlighted by the reduced 
mitochondrial biogenesis observed in the present study. 
Particularly, a reduced Sirt3 expression in older DCM 
hearts, a main mitochondria-localized deacetylase 
involved in the regulation of mitochondrial enzymes 
activity [65, 66], argues for a disturbed mitochondrial 
function. The pivotal role of Sirt3 in cardiovascular 
health/diseases is largely accepted and Sirt3 dysfunction 
is associated with numerous pathologies [67, 68]. 
 
Aside from impaired mitochondrial biogenesis and 
acetylation capacity, numerous mitochondrial ab-
normalities have been reported in patients with DCM 
elsewhere [69–71], which may additionally contribute 
to the mitochondrial dysfunction in older DCM hearts. 
Mitochondrial dysfunction is typically accompanied by 
impaired ATP synthesis with enhanced ROS formation 
[72]. Though we did not measure adenine nucleotide 
homeostasis in the present study, the enhanced 
activation of key metabolic sensors, i.e., AMPK, solely 
in older male DCM hearts suggests the elevation of the 
AMP/ATP or ADP/ATP ratio. Interestingly, a male-
specific downregulation of the main mitochondrial 
antioxidant enzyme SOD2 was found in older DCM 
hearts. Altogether, the data suggest that DCM 
aggravates metabolic and oxidative stress in older hearts 
in both a sex-dependent and -independent manner.  
 
The results of research conducted thus far suggests that 
the higher incidence of cardiac diseases, particularly of 
DCM, in males may be due to the fact that females are 
protected by higher levels of steroid hormones, 17β-
estradiol among others. However, in older, post-
menopausal females, the protective effect of 17β-
estradiol is lost. In fact, older men have higher 17β-
estradiol concentrations in their blood compared to 
older women [73]. Our recent report [32] showed that 
cardiac aging is defined by the decline in mitochondrial 
anti-oxidative defense and a pro-inflammatory shift in 
females but not in males.    
 
An increased inflammatory response accompanied by 
decreased mitochondrial function [74, 75] is typical for 
older hearts.  
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NFκB promotes inflammation in myocardial tissue in 
age-related diseases [76]. In accordance with this 
function, our results showed enhanced NFκB expression 
in DCM hearts in older males. [27, 77]. Pro-
inflammatory mediators are increased in aging under 
certain physiological conditions [78]. In the present 
study, the expression of pro-inflammatory factor IL-12 
was elevated in older DCM hearts only in males, while 
a substantial decrease in IL-10 expression was observed 
in older DCM hearts in a sex-independent manner. A 
reduced IL-10 expression is a typical fingerprint 
observed in cardiac aging [32] as well as in aging 
macrophages [79]; furthermore, IL-10 deficiency 
promotes a detrimental course of inflammation [80]. 
The total amount of cardiac macrophages was elevated 
in DCM patients in this study and accompanied by a 
shift in the IL-12/IL-10 ratio to IL-12 side, which is a 
marker of pro-inflammatory macrophages [81].  
 
Our results, in combination with those from other 
previous studies, suggest an increased inflammatory 
phenotype in older DCM hearts, which is even more 
pronounced in males.  
 
In conclusion, the present study revealed that DCM is 
associated with the downregulation of key metabolic 
regulator Sirt1, diminished mitochondrial biogenesis 
and anti-oxidative defense, and an increased 
inflammatory response in older DCM hearts in both 
sex-dependent and -independent manners. 
 




Human lateral left ventricular (LV) wall tissue from 
patients with idiopathic end-stage DCM was collected 
during organ transplantation (men=10 and women=10) 
and from healthy organ donors (men=16 and 
women=15). The informed consent from all donors or 
their legal guardians was obtained. The patients with 
DCM had ejection fractions (EF) <30%. The tissue was 
frozen in liquid nitrogen immediately after collection 
and stored at -80° C. The patients were between 19 and 
70 years old, while healthy donors were between 17 and 
68 years of age. The control (non-diseased) LV samples 
were divided into 4 groups of young (17-40 years; male: 
n=7 and female: n=7) and old (50-68 years; male: n=9 
and female: n=8) individuals; DCM samples were 
divided into 4 groups of young (19-40 years; male: n=5 
and female: n=5) and old (50-70 years; male: n=5 and 
female: n=5) individuals. 
 
For DCM: Sample collection and the experimental 
protocols were approved by the scientific boards at the 
Heart and Diabetes Centre (HDZ) NRW (21/2013) and 
at the Charité – Universitätsmedizin Berlin (EA2/158/ 
16). All research was performed in accordance with the 
guidelines from the relevant regulatory German 
authorities.  
 
For healthy donors: The scientific board at the 
Hungarian Ministry of Health (ETT-TUKEB: 4991-
0/2010-1018EKU) approved the sample collection and 
the experimental protocols. All research was performed 
in accordance with the German and Hungarian 
regulatory guidelines.  
 
RNA extraction and quantitative real-time PCR 
 
Total RNA from cardiac human tissue was 
homogenized in RNA-Bee (Amsbio, Abbingdon, UK) 
and the Phenol/Chloroform (Roth, Karlsruhe, Germany) 
extraction protocol was used for the RNA isolation. The 
Caliper LabChip bioanalyzer (Agilent Technologies, 
Ratingen Germany) was used to analyze the purity of 
the isolated RNA. Quantitative real-time PCR were 
performed using the Brilliant SYBR Green qPCR 
master mix (Applied Biosystems, Foster City, CA, 
USA). The relative amount of target mRNA was 
determined using the comparative threshold (Ct) 
method as previously described [34]. The mRNA 
contents of target genes were normalized to the 
expression of hypoxanthine phosphoribosyl transferase 
(HPRT).  
 
Protein extraction and immunoblotting 
 
LV samples from DCM and control hearts were 
homogenized in a Laemmli buffer (253mM Tris/HCL 
pH 6.8, 8% SDS, 40% glycerin, 200mM DTT, 0.4% 
bromophenol blue). Proteins were quantified using the 
BCA Assay (Thermo Scientific Pierce Protein Biology, 
Schwerte, Germany). Equal amounts of total proteins 
were separated on SDS-polyacrylamide gels and 
transferred to a nitrocellulose membrane. The 
membranes were immunoblotted overnight with the 
following primary antibodies: AMPK (1:2000, Cell 
Signaling, USA), p-AMPK (1:2000, Thr172, Cell 
Signaling, USA), PGC-1α (1:1000 Abcam, UK), 
TOM40 (1:1000, Abcam, UK), TIM 23 (1:5000, BD, 
USA), Sirt3 (1:1000, Cell Signaling, USA), SOD2 
(1:1000, Santa Cruz, USA), catalase (1:1000, Cell 
Signaling, USA), NFκBp65 (1:200, Santa Cruz, USA) 
and FOXO1 (1:1000, Cell Signaling, USA). Equal 
sample loading was confirmed by analysis of actin 
(1:1000, Santa Cruz, USA), HSP60 (1:1000, Cell 
Signaling, USA) or Ponceau S staining. 
Immunoreactive proteins were detected using ECL Plus 
(GE Healthcare, Buckinghamshire, UK) and quantified 
with ImageLab (version 5.2.1 build 11, Bio-Rad 
Laboratories (USA)). 
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Immunohistochemistry 
 
For immunohistochemistry, 5 µm cryo-sections of 
human LV were fixed in formalin for 1 hour at room 
temperature and subjected to a heat-induced epitope 
retrieval step prior to incubation with anti-CD68 
antibody (clone PGM-1, Agilent Technologies, Santa 
Clara, CA, USA). The detection was performed by the 
LSAB method applying the Dako REAL™ Detection 
System (Agilent Technologies, Santa Clara, CA, USA). 
Nuclei were counterstained with hematoxylin and 
mounted on slides with glycerol gelatin (both Merck 
KGaA, Darmstadt, Germany). Negative controls were 
performed by omitting the primary antibody. Images 
were acquired using an AxioImager Z1 microscope 
(Carl Zeiss MicroImaging, Inc.). Positive cells were 
quantified in 10 high power fields (hpf) (field of vision 
in x400 original magnification). All evaluations were 




The data are given as the mean ± SEM. The GraphPad 
Prism 5 (GraphPad Software, 2003, San Diego, USA) 
was used for statistical analysis. The data were 
evaluated using the non-parametric test (Mann-Whitney 
test for two independent groups). A simple linear 
regression analysis was performed with function lm() in 
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Supplementary Figure 1. DCM effects on Sirt1 expression and AMPK phosphorylation in young patients. Western blot 
expression analysis of Sirt1 (A), AMPK (B) and phosphorylated AMPK (Thr172) (C) performed with human cardiac tissue lysates from young 
control (non-diseased) or DCM men (♂) and women (♀). Proteins were normalized to actin or ponceau. Data are shown as the mean ± SEM 
(n= 5). Representative imaging of western blot analysis; the lanes were run in two gels. All data were normalized to the corresponding control 
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Supplementary Figure 2. DCM effects on expression of mitochondrial proteins in young patients. Western blot analysis and 
statistical analysis of PGC1-α (A), TOM40 (B), TIM23 (C), Sirt3 (D), SOD2 (E) and catalase (F) protein expression performed with human cardiac 
tissue lysates from young control (non-diseased) or DCM men (♂) and women (♀). Proteins were normalized to HSP60 or actin. Data are 
shown as the mean ± SEM (n= 5). Representative imaging of western blot analysis; the lanes were run in two gels. All data were normalized 
to the corresponding control and expressed in relative units (r.u.). 
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Supplementary Figure 3. DCM effects on expression of mitochondrial genes in young patients. Real-time PCR analysis for the 
mitochondrial-encoded genes cox1 (A, B) and mt-nda4 (C, D), as well as the nuclear-encoded genes ndusf1 (E, F), performed with human 
cardiac tissue lysates from young control (non-diseased) or DCM men (♂) and women (♀). Data are shown as the mean ± SEM (n= 5).    
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Supplementary Figure 4. DCM effects on the number of macrophages in cardiac tissue of DCM patients. Representative images 
of cardiac cryosections stained with antibodies against CD68 (A–D). The analyses were performed with myocardium from old control (non-
diseased) and DCM men and women. Magnification: 200x. 
